IRW Consulting

Patrik Elfwing joins IRW Consulting AB as Managing Director

Pressmeddelande   •   Nov 23, 2010 12:03 CET

Patrik Elfwing will join as Managing Director at IRW Consulting AB from 1st January 2011. Patrik is 45-years old and has previously served as Country Manager for Bristol Myers Squibb and as Managing Director Scandinavia at Reebok CCM. Before that he was Sales and Marketing Director for AstraZeneca. In the past he has also worked at Pfizer, Sweden.

 

"Patrik's exceptional strong business skills will be of a great value for our continuous expansion in the CRO market", said Ingela Wiking, CEO at IRW

"I am very excited to assume the position as Managing Director at IRW, and to have the possibility to  work together with a strong team of employees. IRW has accomplished great achievements during the past  years, and we will continue to build values for our customers regarding their clinical drug development" said Patrik Elfwing

Ingela Wiking
CEO
IRW Consulting AB

 

IRW are experts in interacting with Nordic regulatory authorities. We cover the full range of CRO services throughout your products' lifecycle, for studies of all sizes and through all phases and beyond, acting either as a full-responsibility partner or provider of in-sourced expertise.

The IRW team is dedicated and professional, with a wide range of academic competence and solid experience of clinical research, as well as of working with global pharmaceutical and biotech companies, and of interacting with the various regulatory authorities in the Nordic region.

Clinical trial management, data management, biostatistics and pharmacovigilance services

We cover the full range from single-centre to multi-national projects, offering professional clinical trial management, data management, biostatistics and pharmacovigilance services for pharmaceutical, biotechnology and medical device companies. We can manage your project from start to finish, or function as a fully-integrated part of your study team.

At IRW, we are aware of the fact that our customers need to cut timelines and be cost-effective when bringing an investigational product up to registration. In all Nordic countries, we have experienced native-speaking experts handling all regulatory and ethical submissions, as well as local monitoring services and support-to-site. This, together with an excellent network of local investigators, will speed up the regulatory processes, as well as facilitating communications with sites and investigators.

We conduct all our work according to current regulations and guidelines i.e. ICH-GCP, local ethical requirements, the Helsinki Declaration and Sponsor or IRW SOPs. All our procedures and data collected are subject to our in-house Quality Assurance.

Being a local Nordic CRO, we can provide you with our wide-ranging knowledge on local networks, including investigators, both within the private sector and in state-run institutions.